Intratympanic Dexamethasone as First-Line Treatment for Selected Patients With Hearing Loss

2018 ◽  
Vol 69 (3) ◽  
pp. 587-590
Author(s):  
Dragos Cristian Stefanescu ◽  
Razvan Hainarosie ◽  
Viorel Zainea ◽  
Anca Pantea Stoian ◽  
Cornelia Nitipir ◽  
...  
Keyword(s):  
Hearing Loss ◽  
Health Insurance ◽  
Sensorineural Hearing Loss ◽  
Sudden Sensorineural Hearing Loss ◽  
Sensorineural Hearing ◽  
Line Treatment ◽  
First Line ◽  
Intratympanic Dexamethasone ◽  
Nose And Throat ◽  
First Line Treatment

There is no consensus among ENT (ear, nose and throat) physicians on the causes, diagnosis and especially therapeutic approach in sensorineural hearing loss (SSHL). The present paper describes our experience with intratympanic dexamethasone injection as initial treatment for selected patients with the sudden sensorineural hearing loss. The results obtained were fully encouraging. The sustained and coherent approaches of the national ENT society through his section of otoneurology, can lead to a diagnostic and therapeutic consensus in the sensorineural hearing loss. Further, the National Health Insurance House must introduce in the methodological norms the therapeutic variants and the concrete conditions for their realisation, in order to have a common medical practice.

Steroid Administration Approach for Idiopathic Sudden Sensorineural Hearing Loss: A National Survey in China

2020 ◽  
pp. 000348942096887
Author(s):  
Qingxiu Yao ◽  
Zhuang Jiang ◽  
Jiajia Zhang ◽  
Shujian Huang ◽  
Shouhuan He ◽  
...  
Keyword(s):  
Hearing Loss ◽  
Sensorineural Hearing Loss ◽  
Intravenous Injection ◽  
Salvage Therapy ◽  
Salvage Treatment ◽  
Sudden Sensorineural Hearing Loss ◽  
Line Treatment ◽  
First Line ◽  
Steroid Administration ◽  
First Line Treatment

Objective: To optimize a protocol for the steroid administration approach for idiopathic sudden sensorineural hearing loss (ISSNHL) in China. Methods: A questionnaire was distributed to otolaryngologists. The data on demographics, indications for first-line and salvage treatment, such as intratympanic administration of steroids (ITS) and postauricular steroids (PAS), and procedures were analyzed. Results: 74 respondents used oral steroids, 112 used intravenous injections, 10 used ITS and 6 used PAS as a monotherapy for first-line treatment, and 135 used ITS or PAS in conjunction with oral or intravenous injection as a first-line treatment. Of the 249 respondents who used ITS, 97.19% adopted it as salvage therapy. The most commonly used steroid was 0.5 ml dexamethasone at 5 mg/ml and the most common side effect was pain. Of the 174 respondents who used PAS, 94.25% used it as salvage therapy. The most commonly used steroid was 0.5 ml methylprednisolone mixed with 0.5 ml lidocaine. Conclusions: The obtained data suggested that intravenous injection of steroids was the most popular treatment for ISSNHL and that ITS or PAS were used as a salvage treatment in China.

Sign in / Sign up

Export Citation Format

Share Document